GlassScriptPhysician profile
Olga Gilman
NPI 1164946919
$14,135.28
in general payments reported to CMS, 2019-2025
5 companies · $5,230 in 2025
The $5,230 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $727 · 2022: $570 · 2023: $4,553 · 2024: $3,055 · 2025: $5,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,126 · Travel and Lodging: $3,907 · Consulting Fee: $1,800 · Education: $5.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,125.50 |
| Travel and Lodging | $3,907.21 |
| Consulting Fee | $1,800.00 |
| Education | $5.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $13,159.31 | 2021-2025 | Xeomin |
| Galderma Laboratories, L.P. | $608.55 | 2021-2024 | Dysport |
| Allergan, INC. | $172.74 | 2021-2022 | |
| Revance Therapeutics, INC. | $125.00 | 2025 | Daxxify |
| Abbvie INC. | $69.68 | 2023-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Gilman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.